CSL Ltd. — Capital/Financing Update 2005

Feb 28, 2005

1 March 2005

CSL COMPLETES SALE OF JRH BIOSCIENCES

CSL Limited announced today that it has completed the sale of its JRH Biosciences Division (JRH) to Sigma-Aldrich Corporation for US\$370m cash subject to normal closing adjustments.

CSL's Managing Director, Dr Brian McNamee, said, "JRH is now positioned to move into its next stage of development and we hope that Sigma-Aldrich can build on the strategic value that JRH brings to its cell culture reagent business."

Dr McNamee added that he wished the people at JRH who had done so much to build the business over the recent past, every success for the future in continuing to grow and develop that business.

For further information, please contacr:

Mark Dehring Head of Investor Relations CSL Limited Telephone: +613 9389 2818 Email: mark.dehring@csl.com.au

Media

Ms Rachel David Director of Public Affairs CSL Limited Mobile: 0401 775 779 ot Hintons Tim Duncan Telephone: +61 3 9600 1979 Mobile: 0408 441 122